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STUDIUM PRZYPADKU / CLINICAL VIGNETTE
Transcatheter aortic valve implantation (TAVI)  
in a patient with severe aortic insufficiency  
of aortic valve homograft
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We present the case of a 64-year-old female who was admitted to our centre with severe aortic insufficiency and advanced 
heart failure symptoms (NYHA class III–IV). Her medical history included: surgical homograft aortic valve replacement due 
to severe aortic insufficiency 14 years ago, chronic atrial fibrillation, and hypothyroidism. The patient’s logistic EuroSCORE 
was 32%, EuroSCORE II 9.1%, and STS score 3.95%. Preprocedural transthoracic echocardiographic examination revealed 
akinesis of the basal and mid segments of interventricular septum, global hypokinesis of remaining segments with ejection 
fraction of 19%, enlargement of the left ventricle and atrium (diameter of 68 and 43 mm, respectively), regurgitant orifice 
area of 0.3 cm2, regurgitant volume of 58 mL, and regurgi-
tant jet width to left ventricular outflow tract ratio of 66% 
(Fig. 1). An additional transoesophageal echocardiographic 
examination was performed for more precise measurement: 
this showed aortic annulus diameter of 24 mm. Angiography 
and computed tomography were also performed, showing 
no lesions in either the coronary or peripheral arteries. On 
the basis of the abovementioned clinical conditions, the 
Heart Team decided to refer the patient to transcatheter 
aortic valve implantation (TAVI) via femoral access. The 
procedure was performed under general anaesthesia with 
a temporary pacemaker placed through the jugular vein and 
vascular access obtained with 18 Fr sheath by puncture of 
the right femoral artery. Due to lack of calcifications, two 
pig-tail catheters were placed in order to mark the plane 
of the annulus (Fig. 2) and 29 mm Medtronic CoreValveTM 
bioprosthesis was implanted under rapid pacing. Despite 
these preventive measures, the final position of prosthesis 
was too low with moderate-to-severe aortic insufficiency 
(Fig. 3) that persisted even after postdilatation with a 28 mm 
balloon. Therefore, the decision to implant another 29 mm 
CoreValve 10 to 15 mm higher was made. Finally, in control 
imaging, only a mild paravalvular leak was present (Fig. 4), 
and on discharge the ejection fraction had improved to 43%. 
TAVI is an effective treatment option for severe aortic ste-
nosis in inoperable and high-risk patients. However, failure 
(mostly insufficiency) of a previous homograft aortic valve 
poses a challenge for any interventional treatment. In se-
lected patients, TAVI can be a feasible alternative for high 
risk re-operation. TAVI may also be considered in some 
cases of native aortic insufficiency where there is favour-
able anatomy. 
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Figure 1. Severe homograft aortic 
insufficiency in colour Doppler 
imaging
Figure 2. Two pigtail 
catheters marking  
annulus plane (arrows)
Figure 3. Significant residual insufficiency in (A) angiography 
and (B) echocardiography after implantation of first prosthesis
Figure 4. Good result after placement of the second  
CoreValve in both angiography and echocardiography  
(A and B, respectively) with only a trace of regurgitation
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